Margriet J. Löwik

2.1k citations

8 papers · 1.5k indexed · 1 hit paper · h-index 7

Co-authors: Gemma G. Kenter Sjoerd H. van der Burg Marij J.P. Welters Cornelis J.M. Melief A. Rob P.M. Valentijn Gert Jan Fleuren Jaap Oostendorp Lorraine M. Fathers
Topics: Cervical Cancer and HPV Research (7 papers)Immunotherapy and Immune Responses (5 papers)Genital Health and Disease (3 papers)
Cited by: Immunology Oncology Obstetrics and Gynecology
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Cancer Research
Partner nations: Netherlands Australia United States

In The Last Decade

Margriet J. Löwik

8 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia

2009 803 citations Gemma G. Kenter, Marij J.P. Welters et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Margriet J. Löwik

Since Specialization

Citations

This map shows the geographic impact of Margriet J. Löwik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margriet J. Löwik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margriet J. Löwik more than expected).

Fields of papers citing papers by Margriet J. Löwik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margriet J. Löwik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margriet J. Löwik. The network helps show where Margriet J. Löwik may publish in the future.

Co-authorship network of co-authors of Margriet J. Löwik

This figure shows the co-authorship network connecting the top 25 collaborators of Margriet J. Löwik. A scholar is included among the top collaborators of Margriet J. Löwik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margriet J. Löwik. Margriet J. Löwik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	HPV16 synthetic long peptide (HPV16-SLP) vaccination therapy of patients with advanced or recurrent HPV16-induced gynecological carcinoma, a phase II trial 2013 ·Journal of Translational Medicine ·Mariëtte I.E. van Poelgeest,Marij J.P. Welters,Edith M.G. van Esch,Linda F. M. Stynenbosch,(unknown),Els L. van Persijn van Meerten,Muriel van den Hende,Margriet J. Löwik,Dorien M. A. Berends-van der Meer,Lorraine M. Fathers,A. Rob P.M. Valentijn,Jaap Oostendorp,Gert Jan Fleuren,Cornelis J.M. Melief,Gemma G. Kenter,Sjoerd H. van der Burg	148
2	The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study 2013 ·Cancer Immunology Immunotherapy ·Peggy J. de Vos van Steenwijk,Mariëtte I.E. van Poelgeest,Tamara H. Ramwadhdoebé,Margriet J. Löwik,Dorien M. A. Berends-van der Meer,Caroline E. van der Minne,Nikki M. Loof,Linda F. M. Stynenbosch,Lorraine M. Fathers,A. Rob P.M. Valentijn,Jaap Oostendorp,Elisabeth M. Osse,Gert Jan Fleuren,Linda S. Nooij,Marjolein J. Kagie,Bart W.J. Hellebrekers,Cornelis J.M. Melief,Marij J.P. Welters,Sjoerd H. van der Burg,Gemma G. Kenter	52
3	A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions 2012 ·Cancer Immunology Immunotherapy ·Peggy J. de Vos van Steenwijk,Tamara H. Ramwadhdoebé,Margriet J. Löwik,Caroline E. van der Minne,Dorien M. A. Berends-van der Meer,Lorraine M. Fathers,A. Rob P.M. Valentijn,Jaap Oostendorp,Gert Jan Fleuren,Bart W.J. Hellebrekers,Marij J.P. Welters,(unknown),Cornelis J.M. Melief,Gemma G. Kenter,Sjoerd H. van der Burg	76
4	An Unexpectedly Large Polyclonal Repertoire of HPV-Specific T Cells Is Poised for Action in Patients with Cervical Cancer 2010 ·Cancer Research ·Peggy J. de Vos van Steenwijk,Moniek Heusinkveld,Tamara H. Ramwadhdoebé,Margriet J. Löwik,Jeanette M. van der Hulst,Renske Goedemans,Sytse J. Piersma,Gemma G. Kenter,Sjoerd H. van der Burg	70
5	Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses 2010 ·Proceedings of the National Academy of Sciences ·Marij J.P. Welters,Gemma G. Kenter,Peggy J. de Vos van Steenwijk,Margriet J. Löwik,Dorien M. A. Berends-van der Meer,(unknown),Linda F. M. Stynenbosch,Annelies P.G. Vloon,Tamara H. Ramwadhdoebé,Sytse J. Piersma,Jeanette M. van der Hulst,A. Rob P.M. Valentijn,Lorraine M. Fathers,Jan W. Drijfhout,Kees L. M. C. Franken,Jaap Oostendorp,Gert Jan Fleuren,Cornelis J.M. Melief,Sjoerd H. van der Burg	186
6	Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasiabreakdown → 2009 ·New England Journal of Medicine ·Gemma G. Kenter,Marij J.P. Welters,A. Rob P.M. Valentijn,Margriet J. Löwik,Dorien M. A. Berends-van der Meer,Annelies P.G. Vloon,(unknown),Lorraine M. Fathers,Rienk Offringa,Jan W. Drijfhout,Amon R. Wafelman,Jaap Oostendorp,Gert Jan Fleuren,Sjoerd H. van der Burg,Cornelis J.M. Melief	803
7	Robust T-cell responses and clinical responses following long peptide vaccination against high risk HPV-16 2008 ·Cornelis J.M. Melief,Marij J.P. Welters,Margriet J. Löwik,Annelies P.G. Vloon,Jan W. Drijfhout,A. Rob P.M. Valentijn,Amon R. Wafelman,Gert Jan Fleuren,Rienk Offringa,Sjoerd H. van der Burg,Gemma G. Kenter	1
8	An observational longitudinal study to evaluate miction, defecation, and sexual function after radical hysterectomy with pelvic lymphadenectomy for early-stage cervical cancer 2006 ·International Journal of Gynecological Cancer ·Q. D. Pieterse,Cornelis P. Maas,Moniek M. ter Kuile,Margriet J. Löwik,M. A. Van Eijkeren,J. Baptist Trimbos,Gemma G. Kenter	136

About Margriet J. Löwik

Margriet J. Löwik is a scholar working on Microbiology, Immunology and Virology, having authored 8 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cervical Cancer and HPV Research (7 papers), Immunotherapy and Immune Responses (5 papers) and Genital Health and Disease (3 papers). The work is most often cited by research in Immunology (1.1k citations), Oncology (673 citations) and Obstetrics and Gynecology (127 citations). Margriet J. Löwik has collaborated with scholars based in Netherlands, Australia and United States. Frequent co-authors include Gemma G. Kenter, Sjoerd H. van der Burg, Marij J.P. Welters, Cornelis J.M. Melief, A. Rob P.M. Valentijn, Gert Jan Fleuren, Jaap Oostendorp, Lorraine M. Fathers, Dorien M. A. Berends-van der Meer and Annelies P.G. Vloon. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact